Picture of EssilorLuxottica SA logo

EL EssilorLuxottica SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

France's EssilorLuxottica Q1 revenue rises 10.8% on the back of AI glasses

Overview

France eyewear group's Q1 revenue rose 10.8% at constant exchange rates

Double-digit growth in Professional Solutions and Direct to Consumer segments

Company expanded retail footprint in Thailand with Top Charoen deal

Outlook

Company did not provide specific financial guidance for the current or future periods

Result Drivers

AI GLASSES AND RAY-BAN - Co said strong sales of AI glasses and Ray-Ban brand supported growth in North America and EMEA

MYOPIA MANAGEMENT - Myopia management portfolio grew 26%, with China up 18% and retail expansion contributing

RETAIL EXPANSION - Top Charoen deal added around 2k stores in Thailand, expanding the Group’s network to nearly 20k locations

Company press release: ID:nGNE4WXqj1

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 RevenueEUR 7.13 bln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 23 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell" The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy" Wall Street's median 12-month price target for Essilorluxottica SA is €320.00, about 54.8% above its April 21 closing price of €206.70 The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 34 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on EssilorLuxottica SA

See all news